Bioreactors and Fermenters Market, By Type (Single-use Bioreactors, and Multiple-use Bioreactors), By Process (Fed batch, Continuous, and Batch), By End User (Biopharmaceutical companies, CROs, and Academic & Research Institutes), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030

Report Code: PMI465521 | Publish Date: April 2024 | No. of Pages: 180

Global Bioreactors And Fermenters Market Companies

  • Finesse Solutions, Inc.
  • Applikon Biotechnology B.V.
  • PBS Biotech, Inc.
  • Danaher Corporation
  • Sartorius AG
  • Eppendorf AG
  • ZETA Holding GmbH
  • GE Healthcare
  • Solaris Biotechnology srl
  • PIERRE GUERIN TECHNOLOGIES
  • Thermo Fisher Scientific Inc.
  • Merck KGaA.

Recent News:

  • In May 2022, Pall Corporation announced that their ICELL is a nano bioreactor helped the Institute of Biomedicine of Seville (IBIS) to broaden viral vectors for CAR-T therapy
  • In May 2021, Beckman Coulter Life Sciences, announced launched of its next-technology Biolector XT Microbioreactor in Germany. The BioLector XT Microbioreactor permits cultivation parameter monitoring, high-throughput pressure screenings, and feeding approach optimization.
  • In February 2021, WuXi Biologics`s MFG5 Drug Substance (DS) production facility in China efficaciously released a GMP operation with a potential of 36,000L, deploying 9 4,000L single-use bioreactors. As a first-rate landmark withinside the company's international potential planning, the GMP release of MFG5 brings WuXi Biologics' present day potential to 90,000L, substantially improving the functionality to permit international partners.